ArticleNPJ vaccines2025

TLR7/8/9 agonists and low-dose cisplatin synergistically promotes tertiary lymphatic structure formation and antitumor immunity.

Shuting Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.